Ultimately, the notion of a negative impact of obesity on AMH in healthy women with regular menstrual cycles may be deemed uncertain at this time—or at best limited to women with severe obesity, warranting further investigations to address the limitations of the current evidence. The gene discussed is AMH; the disease is obesity due to melanocortin 4 receptor deficiency.